Cholesterol Ratio Calculator

What is the total cholesterol to HDL ratio?

The total cholesterol to HDL cholesterol ratio compares all cholesterol carried in the blood with the cholesterol carried in high-density lipoprotein particles.

The calculation uses two results from the same lipid panel: total cholesterol divided by HDL cholesterol. Both values must use the same unit, usually mg/dL or mmol/L. Units cancel, so the result is a unitless number. A higher ratio often reflects more cholesterol in atherogenic particles, less HDL cholesterol, or both. Cohort studies associate higher ratios with more cardiovascular events, but association does not make the ratio a treatment target. Current US dyslipidemia guidance uses the full lipid profile, estimated cardiovascular risk, medical history, and selected risk enhancers. It does not recommend treating a ratio in isolation.

HDL cholesterol is a risk marker. It is not a direct measure of how well HDL particles remove cholesterol from tissues. Genetic studies and trials of medicines that raise HDL cholesterol have not shown that raising the laboratory number by itself reliably prevents events. A low ratio can add context without proving that a person is protected.

[1][2][3]

Formula and required inputs

Use the equation: total cholesterol to HDL ratio = total cholesterol ÷ HDL cholesterol.

Do not divide LDL by HDL, and do not mix a total cholesterol value in mg/dL with an HDL value in mmol/L. If the report uses the same unit for both, no conversion is needed. The inputs should come from one blood draw. Combining total cholesterol from an older report with a newer HDL result creates a noncontemporaneous ratio. Record the collection date, whether the sample was fasting, and whether lipid-lowering treatment had changed before the draw.

A standard lipid profile directly measures total cholesterol, HDL cholesterol, and triglycerides, then reports or estimates LDL cholesterol. It also permits non-HDL cholesterol, calculated as total cholesterol minus HDL cholesterol. These related measures answer different questions and should remain visible when the ratio is reviewed.

[1][4]

Worked examples

Example 1: total cholesterol is 210 mg/dL and HDL cholesterol is 60 mg/dL. The ratio is 210 ÷ 60 = 3.5. Non-HDL cholesterol is 210 minus 60 = 150 mg/dL.

The ratio supplies context. The non-HDL result shows that 150 mg/dL of cholesterol is carried outside HDL particles. Example 2: total cholesterol is 180 mg/dL and HDL cholesterol is 30 mg/dL. The ratio is 180 ÷ 30 = 6.0. Total cholesterol alone may appear unremarkable, but the low HDL produces a high ratio. The clinician still needs LDL, triglycerides, blood pressure, diabetes status, smoking history, age, and treatment history before estimating risk.

Example 3 uses SI units. Total cholesterol is 5.4 mmol/L and HDL cholesterol is 1.8 mmol/L. The ratio is 3.0. Converting both values to mg/dL would produce the same ratio because the common conversion factor cancels. Rounding the final ratio to one decimal place is adequate for interpretation.

[1][4]

How to use this cholesterol ratio calculator

Copy total cholesterol and HDL cholesterol from the same laboratory report. Confirm that both values use mg/dL or both use mmol/L.

Enter the values without unit conversion, calculate the ratio, and keep one decimal place. Check the arithmetic manually if the output will inform a clinical conversation. Next, read the ratio beside LDL cholesterol, non-HDL cholesterol, and triglycerides. Note current medicines, pregnancy, recent acute illness, major weight change, and whether the sample followed the laboratory instructions. Compare with prior values only when methods and clinical circumstances are reasonably similar.

Use the result as a prompt for risk assessment, not as permission to start, stop, or change medicine. A clinician may use a validated cardiovascular risk equation plus family history, chronic kidney disease, diabetes, inflammatory disease, lipoprotein(a), apolipoprotein B, or coronary calcium when those details could change management.

Seek clinical review promptly when the report shows LDL cholesterol at or above 190 mg/dL, triglycerides at or above 500 mg/dL, a possible inherited lipid disorder, or a large unexplained change. Existing cardiovascular disease, diabetes, pregnancy, and lipid treatment also require individualized interpretation.

[1][4][5]

Interpreting a low, middle, or high ratio

There is no single guideline-endorsed ratio cutoff that diagnoses cardiovascular disease or determines treatment.

Published educational ranges sometimes label values near 3.5 as favorable and values near 5 as high, but those labels come from population distributions and observational associations. They are not universal clinical thresholds. In a Framingham analysis of middle-aged and older adults, a ratio at or above 5 was associated with incident ischemic stroke, yet the study could not establish that changing the ratio itself would prevent stroke. In the ARIC cohort, a ratio that was high relative to LDL or non-HDL cholesterol identified additional risk in some participants, especially those with diabetes. These findings support contextual use, not ratio-only prescribing.

A favorable ratio can hide high LDL cholesterol when HDL is also high. A high ratio can arise mainly from low HDL even when LDL is modest. Review the components rather than assuming the same cause for every result.

[2][5][6]

Fasting, illness, and repeat testing

Most adults can have an initial lipid profile without fasting.

Total cholesterol and HDL cholesterol usually change little after ordinary food intake, so their ratio is less meal-sensitive than triglyceride-based calculations. Fasting measurement becomes more useful when triglycerides are known to be high, a prior nonfasting result is difficult to interpret, or an inherited lipid disorder is suspected. Acute infection, hospitalization, recent surgery, major weight loss, pregnancy, poorly controlled diabetes, thyroid disease, liver disease, kidney disease, and some medicines can alter lipid results. Alcohol intake can raise triglycerides. A single unusual value should be compared with the clinical setting and prior results.

Biological and laboratory variation means repeat testing may be appropriate before a long-term decision, particularly when the result is unexpected or close to a decision threshold in another lipid measure. Immediate confirmation is not a reason to delay care when severe hypercholesterolemia, very high triglycerides, or established cardiovascular disease is present.

[1][4][7]

Ratio versus LDL, non-HDL, and apolipoprotein B

LDL cholesterol remains a central causal lipid measure and treatment focus.

Non-HDL cholesterol captures cholesterol in LDL, VLDL remnants, intermediate-density lipoproteins, and lipoprotein(a). Apolipoprotein B approximates the number of atherogenic particles because each major atherogenic particle carries one apoB molecule. The ratio may be discordant with LDL or non-HDL cholesterol. In a cross-sectional analysis of about 1.3 million US adults, substantial percentile discordance was common, particularly among people with higher triglycerides and lower HDL. Cross-sectional discordance does not prove that ratio-guided treatment improves outcomes.

Current guidance favors non-HDL cholesterol and selective apoB testing when triglycerides, diabetes, obesity, or very low LDL make cholesterol content less representative of particle number. Advanced lipoprotein testing is not routine because methods differ and many results do not improve decisions beyond standard lipids, apoB, and lipoprotein(a).

[1][2][8]

Population and life-stage caveats

Cardiovascular risk at the same ratio differs by age, sex, blood pressure, smoking, diabetes, kidney function, and prior disease.

Risk equations combine several of these variables because a lipid ratio alone cannot estimate an individual probability. Older cohort findings may not transfer perfectly to younger adults or to populations underrepresented in the original studies. Pregnancy changes lipid concentrations as gestation advances, so general adult ranges should not guide treatment without obstetric context. Children require pediatric lipid interpretation and family-based evaluation when familial hypercholesterolemia is possible. Adults older than the validated age range of a risk equation need individualized assessment.

Race and ethnicity are social and population descriptors, not biological corrections for the ratio. Some risk models have limited calibration across groups because their development cohorts lacked representation. Clinicians should consider family history, ancestry-linked inherited disorders, access to care, and the limits of the chosen risk model without inventing a race-specific ratio cutoff.

[1][6][9]

What an unusual ratio cannot diagnose

A high ratio can accompany insulin resistance, type 2 diabetes, smoking, physical inactivity, obesity, high triglycerides, hypothyroidism, kidney disease, liver disease, or an inherited lipid disorder. It does not identify which cause is present.

Evaluation may include medication review, fasting glucose or A1C, thyroid testing, kidney and liver assessment, and family history when clinically indicated. A low ratio does not exclude atherosclerosis, familial hypercholesterolemia, elevated lipoprotein(a), hypertension, or diabetes. It also cannot distinguish functional from dysfunctional HDL particles. Symptoms such as chest pressure, shortness of breath, focal weakness, or sudden speech difficulty require urgent assessment rather than interpretation through a lipid calculator.

The ratio is unsuitable for monitoring a specific drug response when the treatment goal is defined by LDL cholesterol, non-HDL cholesterol, apoB, or percentage LDL reduction. Use the measure named in the treatment plan and keep the ratio as supplementary information.

[1][2][8]

When clinical confirmation is required

Clinical confirmation is required before diagnosing a lipid disorder or changing therapy.

The clinician confirms the original values, reviews secondary causes and adherence, estimates absolute cardiovascular risk, and checks whether the person belongs to a group with direct treatment recommendations. A ratio cannot establish familial hypercholesterolemia or determine statin intensity. Discuss the result with a clinician when LDL is severely elevated, triglycerides are very high, early cardiovascular disease runs in the family, or the ratio remains high despite lifestyle changes. Review is also appropriate for children, pregnancy, diabetes, chronic kidney disease, known cardiovascular disease, or adverse effects from lipid medicine.

Lifestyle changes should target established risk factors rather than an isolated ratio. Replacing saturated fat with unsaturated fat, avoiding trans fat, choosing fiber-rich foods, being physically active, stopping tobacco exposure, and treating blood pressure or diabetes can improve the overall risk profile. Alcohol should not be started to raise HDL cholesterol.

[1][3][7][10]

How it works

Ratio = total cholesterol / HDL. Optimal <3.5; average 3.5 to 5.0; high >5.0.

Frequently asked questions

• What is a good cholesterol ratio?Below 3.5 is optimal. Below 5.0 is acceptable for most adults.

Related calculators

References

1. ACC and AHA Joint Committee on Clinical Practice Guidelines. 2026 Guideline on the Management of Dyslipidemia
2. Elshazly et al.. Patient-Level Discordance of the Total Cholesterol to HDL-C Ratio With LDL-C and Non-HDL-C
3. Barter et al.. HDL Cholesterol and Cardiovascular Risk
4. CDC. Testing for Cholesterol
5. Quispe et al.. Total Cholesterol to HDL-C Ratio Discordance and ASCVD in the ARIC Study
6. Pikula et al.. Lipid and Lipoprotein Measurements and Ischemic Vascular Events in the Framingham Study
7. National Heart, Lung, and Blood Institute. Blood Cholesterol
8. Sniderman et al.. Apolipoprotein B and Cardiovascular Risk
9. National Heart, Lung, and Blood Institute. Assessing Cardiovascular Risk: Systematic Evidence Review
10. Sacks et al.. Dietary Fats and Cardiovascular Disease: A Presidential Advisory